Avicena Revenue and Competitors
Estimated Revenue & Valuation
- Avicena's estimated annual revenue is currently $2.4M per year.
- Avicena's estimated revenue per employee is $98,000
Employee Data
- Avicena has 24 Employees.
- Avicena grew their employee count by -66% last year.
Avicena's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Marketing | Reveal Email/Phone |
2 | Lead App Software Developer | Reveal Email/Phone |
Avicena Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 17 | N/A | N/A | N/A |
#2 | $0.6M | 8 | 0% | N/A | N/A |
#3 | $13.2M | 94 | 6% | N/A | N/A |
#4 | $78.4M | 441 | 0% | $6.8M | N/A |
#5 | $12M | 86 | -1% | N/A | N/A |
#6 | $66.1M | 372 | -3% | $131.5M | N/A |
#7 | $0.6M | 8 | -50% | N/A | N/A |
#8 | $0.3M | 4 | 33% | N/A | N/A |
#9 | $0.6M | 9 | N/A | N/A | N/A |
#10 | $2.6M | 27 | N/A | N/A | N/A |
What Is Avicena?
Avicena is a medical device company developing an algorithm and new sensor platform that reveal real time information about cardiovascular function. Through Avicena's platform, live cardiovascular data is streamed directly to a mobile device, providing critical information to patients and physicians through our mobile app. Our goal is to make health data clinically relevant and consumer friendly.
keywords:N/AN/A
Total Funding
24
Number of Employees
$2.4M
Revenue (est)
-66%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avicena News
The Avicena Sentinel saliva sampling approach involves sensitive molecular processes and ultra-high throughput technology for screening...
Avicena's demonstration of record low power consumption with its LightBundle interconnect technology is proof of the advances Lumileds has...
Avicena emerged last year with an approach to chip-to-chip interconnect that combines microLED optical sources with multicore fiber.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.7M | 24 | -8% | N/A |
#2 | $2.4M | 24 | N/A | N/A |
#3 | N/A | 24 | 9% | N/A |
#4 | $2.6M | 25 | -4% | N/A |
#5 | $2.5M | 25 | N/A | N/A |